VOLITIONRX LTD — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
VolitionRx filed an 8-K on 2026-08-07 reporting Item 3.02 (unregistered sales of equity securities) for the period ending 2026-08-06. The filing provides no specific details: no counterparty name, share count, price, dollar amount, or terms are disclosed in the accessible text. The company is a ~$72.9M market-cap diagnostics firm.
Why this rating
Without disclosed terms (shares, price, counterparty), cannot assess materiality. Standard Item 3.02 disclosure format typical for small biotech; routine filing absent specifics.
Extracted items
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.